Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane

Authors :: Willemsen, A.E.C.A.B.
Geus-Oei, L.F. de
Boer, Maaike de
Tol, J.
Kamm, Yvonne
Jong, P.C. de
Jonker, M.A.
Aarntzen, E.H.J.G.
Gerritsen, W.R.
Herpen, C.M.L. van
Erp, N.P. van
Willemsen, A.E.C.A.B.
Geus-Oei, L.F. de
Boer, Maaike de
Tol, J.
Kamm, Yvonne
Jong, P.C. de
Jonker, M.A.
Aarntzen, E.H.J.G.
Gerritsen, W.R.
Herpen, C.M.L. van
Erp, N.P. van
Source :: Targeted Oncology; 641; 648; 1776-2596; 5; 13; ~Targeted Oncology~641~648~~~1776-2596~5~13~~
Publication Year :: 2018
Abstract: Item does not contain fulltext

Database :: OAIster
Journal :: Targeted Oncology; 641; 648; 1776-2596; 5; 13; ~Targeted Oncology~641~648~~~1776-2596~5~13~~
Publication Type :: Electronic Resource
Accession number :: edsoai.on1283996635
Document Type :: Electronic Resource

Tools